These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11894997)

  • 21. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do CD8(+)CD25(+) cells predict immune reconstitution syndrome in HIV-positive patients who begin HAART?
    Cianchetta-Sívori M; Raso S; Fernández-Guerrero M; Górgolas M; García R
    AIDS; 2007 Nov; 21(17):2347-9. PubMed ID: 18090286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antiretroviral therapy on immune reconstitution.
    Autran B
    Antivir Ther; 1999; 4 Suppl 3():3-6. PubMed ID: 16021864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
    Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M
    J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
    J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
    Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
    J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
    Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
    Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.
    Jesser RD; Li S; Weinberg A
    Virology; 2006 Sep; 352(2):408-17. PubMed ID: 16782163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulation in HIV-1 infection in the HAART era.
    Imami N; Sullivan AK; Gotch FM
    J HIV Ther; 2001 Nov; 6(4):77-84. PubMed ID: 11740408
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapy clinical trials for HIV.
    Statham S; Morgan RA
    Curr Opin Mol Ther; 1999 Aug; 1(4):430-6. PubMed ID: 11713756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Possibility of immunotherapy against HIV infection].
    Matsushita S
    Tanpakushitsu Kakusan Koso; 2001 Apr; 46(5):638-43. PubMed ID: 11296361
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunologic and clinical aspects of human immunodeficiency virus infection.
    Romagnani S
    Allergy; 1994 Oct; 49(9):685-95. PubMed ID: 7695056
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic modification of T-cell clones for therapy of human viral and malignant diseases.
    Greenberg PD; Finch RJ; Gavin MA; Kalos M; Lewinsohn DA; Lonergan M; Lord JD; Nelson BH; Ohlén C; Sing AP; Warren EH; Yee C; Riddell SR
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S100-5. PubMed ID: 9619278
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune reconstitution disease (IRD) increasing; recognition, management important.
    Murphy MJ
    HIV Clin; 2004; 16(4):1-3. PubMed ID: 15595161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.